📣 VC round data is live. Check it out!
- Public Comps
- EQT
EQT Valuation Multiples
Discover EQT's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Ameriprise Financial, Sun Life, Power Corporation of Canada, Banco BTG Pactual and more.
EQT Overview
About EQT
Swedish conglomerate Investor AB set up EQT as its private equity division in 1994. In its early days, EQT focused primarily on private equity investments in Sweden and the rest of Scandinavia. Today, EQT is one of the largest global private-market investors, with funds that focus on private equity, real estate, and infrastructure globally. Investor AB retains a minority stake.
Founded
1994
HQ

Employees
1.9K
Website
Sectors
Financials (LTM)
EV
$36B
Valuation Multiples
Start free trialEQT Financials
EQT reported last 12-month revenue of $3B and EBITDA of $2B.
In the same LTM period, EQT generated $3B in gross profit, $2B in EBITDA, and $1B in net income.
Revenue (LTM)
EQT P&L
In the most recent fiscal year, EQT reported revenue of $3B and EBITDA of $2B.
EQT is profitable as of last fiscal year, with gross margin of 64%, EBITDA margin of 58%, and net margin of 27%.
Financial data powered by Morningstar, Inc.
EQT Stock Performance
EQT has current market cap of $40B, and enterprise value of $36B.
Market Cap Evolution
EQT's stock price is $33.90.
EQT share price decreased by 2.8% in the last 30 days, and by 0.5% in the last year.
EQT has an EPS (earnings per share) of $0.73.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $36B | $40B | -2.0% | -2.8% | 8.3% | -0.5% | $0.73 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEQT Valuation Multiples
EQT trades at 10.9x EV/Revenue multiple, and 18.4x EV/EBITDA.
EV / Revenue (LTM)
EQT Financial Valuation Multiples
As of June 4, 2026, EQT has market cap of $40B and EV of $36B.
EQT has a P/E ratio of 37.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified EQT Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


EQT Margins & Growth Rates
EQT grew revenue by 3% and EBITDA by 9% in the last fiscal year.
In the most recent fiscal year, EQT reported gross margin of 64%, EBITDA margin of 58%, and net margin of 27%.
EQT Margins
EQT Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
EQT Operational KPIs
EQT's revenue per employee in the last FY averaged $1.7M, while opex per employee averaged $0.8M for the same period.
EQT's Rule of 40 is 69% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
EQT's Rule of X is 82% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
EQT Competitors
EQT competitors include Ameriprise Financial, Sun Life, Power Corporation of Canada, Banco BTG Pactual, ORIX, Prudential, State Street, Strategy, Northern Trust and 3i Group.
Most EQT public comparables operate across PE & VC and Asset Management.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.0x | 2.0x | 6.5x | 6.4x | |||
| 1.5x | 5.1x | 10.2x | 10.1x | |||
| 1.8x | 3.5x | - | - | |||
| 5.0x | 7.2x | - | - | |||
| 7.3x | 3.9x | - | 29.5x | |||
| 1.0x | 1.1x | 7.2x | 7.4x | |||
| 1.5x | 1.4x | - | - | |||
| 131.9x | 129.1x | 1339.2x | 1670.7x | |||
This data is available for Pro users. Sign up to see all EQT competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by EQT
EQT has acquired 171 companies to date.
Last acquisition by EQT was on April 22nd 2026. EQT acquired Kakaku.com for $3B (EV/Revenue multiple available to Pro users).
Latest Acquisitions by EQT
| Description | Kakaku.com Inc. is a Japan-based internet company operating various web services. The company operates through four segments. The Incubation Business includes real estate and housing site Smity, travel review site Fort Travel, movie information site Movie.com, automotive site web CG, dynamic package systems, and the bus comparison site Bus Comparison Navi. The Job Box Business operates the job search site Job Box and job information site Jobcube. The Kakaku.com Business operates the purchasing support site Kakaku.com and engages in insurance services through Kakaku.com Insurance Co., Ltd. The Tabelog Business operates the restaurant search and reservation site Tabelog. It generates the majority of its revenue from the Tabelog business segment. | Urbaser is a Madrid-headquartered environmental services firm, part of Firion Investments, offering street cleaning, waste collection and transport, urban waste treatment, recycling, water cycle management, and landscaping across multiple continents. Founded in 1990, the company serves municipal contracts in Spain, Italy, and Latin America with comprehensive urban hygiene solutions. | Coller Capital is a London-headquartered firm investing in private equity secondaries. Founded in 1990, it acquires limited partner interests and direct portfolios from sellers seeking liquidity, with deals ranging from $1 million to over $1 billion. The company manages diverse assets including fund stakes and LP positions globally. | Arlanda Express is a high-speed train operator providing direct rail service from Stockholm Arlanda Airport to Stockholm Central Station. | |
| HQ Country | |||||
| HQ City | Tokyo | Madrid | London | - | |
| Deal Date | 22 Apr 2026 | 12 Feb 2026 | 22 Jan 2026 | 22 Dec 2025 | |
| Valuation | $3B | $7B | $4B | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all EQT acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Investments by EQT
EQT has invested in 122 companies to date.
Latest investment by EQT was on April 26th 2026. EQT invested in Vinted in their $1B Secondary - private round (EV/Revenue multiple available to Pro users).
Latest Investments by EQT
| Description | Vilnius-headquartered Vinted runs a peer-to-peer online marketplace for second-hand fashion, active in 20 countries across Europe and the United States. The platform facilitates buying, selling, and swapping clothing, accessories, and shoes for women, men, and children via mobile apps with chat and bundle discounts. Valued at over 4 billion euros, Vinted processes tens of millions of listings monthly and partners with payment providers like PayPal for secure transactions. | Pulnovo Medical is a Chinese medtech firm pioneering radiofrequency ablation catheters for pulmonary hypertension treatment. Its flagship DragonFly system received China NMPA approval in 2021 and CE Mark for European markets. Established in 2013 and headquartered in Wuxi, Jiangsu Province, the company holds global patents for its endovascular RF technology and expands into atrial fibrillation ablation devices. | Kelda is a holding company owning Yorkshire Water, which provides water and sewerage services to 5.4 million customers in Yorkshire and the Humber region of northern England. Yorkshire Water collects revenue from customer charges for water delivery, wastewater treatment, and infrastructure maintenance under Ofwat regulation. Headquartered in Bradford, Kelda has remained private since its 2006 delisting, backed by investors including the Ontario Teachers' Pension Plan. | Neurent Medical is a Galway-based medical device company creating radiofrequency treatments for chronic rhinosinusitis with nasal polyps. Its NEUROMARK system received FDA clearance for tissue reduction in adult patients, offering a minimally invasive alternative to surgery. Founded in 2015 in Oranmore, Ireland, the firm targets inflammatory sino-nasal conditions through precise ablation technologies. | |
| HQ Country | |||||
| HQ City | Vilnius | Wuxi | Bradford | Galway | |
| Deal Date | 26 Apr 2026 | 19 Apr 2026 | 10 Mar 2026 | 11 Feb 2026 | |
| Round | Secondary - private | Series D | Undisclosed stage | Series C | |
| Raised | $1B | $100M | undisclosed | $74M | |
| Investors | EQT; Lombard Odier Investment Managers; Pinegrove Opportunity Partners; Schroders Capital; Teachers’ Venture Growth; BlackRock | EQT; Gaorong Capital; HSG; Lilly Asia Ventures; Medtronic; OrbiMed; Qiming Venture Partners | EQT | Atlantic Bridge; Enterprise Ireland; EQT; Fountain Healthcare Partners; MVM Life Science Partners; Sofinnova Partners | |
| Valuation | $9B | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all EQT investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout EQT
| When was EQT founded? | EQT was founded in 1994. |
| Where is EQT headquartered? | EQT is headquartered in Sweden. |
| How many employees does EQT have? | As of today, EQT has over 1K employees. |
| Who is the CEO of EQT? | EQT's CEO is Christian Sinding. |
| Is EQT publicly listed? | Yes, EQT is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of EQT? | EQT trades under EQT ticker. |
| When did EQT go public? | EQT went public in 2019. |
| Who are competitors of EQT? | EQT main competitors include Ameriprise Financial, Sun Life, Power Corporation of Canada, Banco BTG Pactual, ORIX, Prudential, State Street, Strategy, Northern Trust, 3i Group. |
| What is the current market cap of EQT? | EQT's current market cap is $40B. |
| What is the current revenue of EQT? | EQT's last 12 months revenue is $3B. |
| What is the current revenue growth of EQT? | EQT revenue growth (NTM/LTM) is 17%. |
| What is the current EV/Revenue multiple of EQT? | Current revenue multiple of EQT is 10.9x. |
| What is the current EBITDA of EQT? | EQT's last 12 months EBITDA is $2B. |
| What is EQT's EBITDA margin? | EQT's last 12 months EBITDA margin is 59%. |
| What is the current EV/EBITDA multiple of EQT? | Current EBITDA multiple of EQT is 18.4x. |
| What is the current FCF of EQT? | EQT's last 12 months FCF is $2B. |
| What is EQT's FCF margin? | EQT's last 12 months FCF margin is 47%. |
| What is the current EV/FCF multiple of EQT? | Current FCF multiple of EQT is 23.5x. |
| How many companies EQT has acquired to date? | As of June 2026, EQT has acquired 170 companies. |
| What was the largest acquisition by EQT? | $14B acquisition of Zayo on 9th March 2020 was the largest M&A EQT has done to date. |
| What companies EQT acquired? | EQT acquired Zayo, Galderma, PAREXEL, BPEA EQT, Urbaser, Dechra Pharmaceuticals, Reworld Holding Corporation, Calisen, Cerba HealthCare S.A.S., First Student, and 160 other companies. |
| In how many companies EQT has invested to date? | As of June 2026, EQT has invested in 122 companies. |
| In what companies EQT invested in? | EQT invested in IVC Evidensia, Sitecore, Beijer Ref, Vinted, Douzone, Mollie, Wolt, O2 Power, ReliaQuest, Epidemic Sound, ManyPets, Lovable, Mews, Mambu, Cirba Solutions, TravelPerk, Electra Therapeutics, Arvelle Therapeutics, Noema Pharma, VectorY, and 102 other companies. |
See public comps similar to EQT
Lists including EQT
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.






